Prices delayed by at least 15 minutes | Print


Fusion Antibodies PLC (FAB)

ORD 4P
Sell: 3.7p|Buy: 3.8p|Change: 0.05 (-1.30%)

Open 

3.85p


Previous close 

3.85p


Trade high 

3.9p


Volume 

161,817


Year high 

50.00p


Year low 

3.02p


Dividend yield 

-


Market capitalisation 

£3.62 mn


P/E ratio 

-


ISIN 

GB00BDQZGK16


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Fusion Antibodies PLC- 2.53
FTSE AIM All Share+ 0.35
More...

Company profile

Fusion Antibodies PLC offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly inthe areas of cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202404:29:483.8341.29
28/03/202404:28:093.8260.99
28/03/202404:13:443.7027,500277.65
28/03/202404:12:423.7025,600207.31
28/03/202403:40:233.9762.96

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.